OOIR: Observatory of International Research

Papers

(The TQCC of Dermatologic Clinics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Systemic Therapy for Vascular Anomalies and the Emergence of Genotype-Guided Management	95
Pediatric Dermatology Part II	41
Neutrophilic Dermatoses: A Medley of Inflammatory Cutaneous and Systemic Disorders	33
Neutrophilic Dermatoses	28
Contributors	23
Diagnostic Imaging	22
Contents	22
Contents	22
Contributors	20
The Psoriasis Treatment Pipeline	20
Prevention of Psoriatic Arthritis	18
Tips, Tricks, and Pearls to Expertly Treat Common Pediatric Dermatologic Conditions	17
Quality of Life with Neutrophilic Dermatoses	17
The Science, Art, and Delivery of Pediatric Dermatologic Care in the Twenty-First Century	15
Comparative Clinical and Histomorphologic Evaluation of the Effectiveness of Combined Use of Calcium Hydroxyapatite and Hyaluronic Acid Fillers for Aesthetic Indications	15
Food and Drug Administration’s Role in Dermatology	14
Gender Equity in Medicine and Dermatology in the United States	13
Diagnosis of Melanonychia	12
Cutaneous Mesenchymal Sarcomas	12
The Social Determinants of Health and Their Impact on Dermatologic Health, Part 1	11
Diversity, Equity, and Inclusion in Dermatology Residency	11
Diversity, Equity, and Inclusion in Dermatology	11
Copyright	10
Forthcoming Issues	10
Starting a Solo Practice	10

Economics of a Dermatology Practice	10
Pediatric Nail Disorders	10
Basic Legal Considerations in Starting and Maintaining a Dermatology Practice	10
Expanding Treatment Indications Beyond the Tear Trough Defect	9
Hot Topics in Cosmetic Dermatology	9
Preventative Options and the Future of Chemoprevention for Cutaneous Tumors	9
Copyright	8
Racial and Ethnic Disparities in Research and Clinical Trials	8
Racial and Ethnic Health Disparities in Dermatology	7
Interventional Treatment of Vascular Anomalies	7
The Impact of the COVID-19 Pandemic on Global Health Dermatology	7
Nail is Systemic Disorders: Main Signs and Clues	7
Capillary Malformations	7
Mohs Micrographic Surgery for Melanoma	7
Addressing Climate-Related Health Impacts During the Patient Encounter	7
How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?	7
Adnexal and Sebaceous Carcinomas	6
A Canvas of Contemporary Insights into Clinical Vitiligo	6
Management of Nail Unit Melanoma	6
Innovation in Dermatomyositis	6
Psoriasis Comorbidities and Their Treatment Impact	6
Clinical Relevance of the Microbiome in Pediatric Skin Disease: A Review	6
Copyright	6
Contributors	6
Skin Cancer in Skin of Color	5
Long-Term Impact of Atopic Dermatitis on Quality of Life	5
Laser Surgery for Dermatologic Conditions in Pediatric Patients	5
Oral Psoriasis Therapies	5
Hidradenitis Suppurativa	5
Contributors	5
Innovations in Hyperpigmentation	5
The Role of Food Allergy in Atopic Dermatitis	5
Cutaneous Sarcoidosis	5
Keloids and Hypertrophic Scars	4
COVID-19 Pediatric Dermatology	4
Musings from a Bent Arrow	4
Pyoderma Gangrenosum	4
Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease	4
Cutaneous Paraneoplastic Syndromes with Nail Involvement	4
From Geraniums to Guadalajara on the Virtues of Early Retirement	4
Coronavirus Disease 2019 and Race in Dermatology	4
Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services	4
Copyright	4
Contributors	3
Contributors	3
Morbilliform Eruptions in the Hospitalized Child	3
The Effects of Cosmetic Procedures on the Youth	3
Forthcoming Issues	3
From Clinic to Hospital and Gold Standard to Substandard: The Complexities of Care of Pediatric Patients	3
Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis	3

The Hair Comeback	3
New Diagnostic Tools to Evaluate Hair Loss	3
Regulation of Medical Devices for Dermatology	3
Forthcoming Issues	3
Disparities in Care for Psoriasis	3
Combination Approaches for Combatting Hair Loss	3
Dermatology Drugs for Children—U.S. Food and Drug Administration Perspective	3
Measuring What Matters to Patients in Dermatology Drug Development	3
Contributors	3
Copyright	3